The Philippines will likely start by end of this month or early November its “Mix and Match” trial or MnM study to determine the safety and immunogenicity of mixing different coronavirus disease (COVID-19) vaccines and vaccine platforms in Filipino adults. The DOST had bared around 400 doses of Sinovac vaccines have already been delivered to the Marikina City site for the dry run. For Davao, an MOU (memorandum of understanding)/MOA (memorandum of agreement) between PSAAI and the LGU will precede the dry run,” Guevara said. READ MORE: https://mb.com.ph/2021/10/22/dost-ph-covid-19-vaccine-mix-and-match-trial-may-start-soon/The project, “A study evaluating the safety and immunogenicity of mixing different COVID-19 vaccines and vaccine platforms in Filipino adults”, is expected to enroll 3,000 unvaccinated participants aged 18 years old and above. The DOST official expressed hope that by “late December or early January” they will know the best vaccines or vaccine platforms that can be mixed.

Source: Manila Bulletin October 25, 2021 05:39 UTC